[1]
H. Nazaryan, Y. Liu, E. Sirotich, J. Duncan, I. Nazy, and D. . Arnold, “Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience in Canada”, Can Journ Gen Int Med, vol. 15, no. 4, pp. 28-35, Nov. 2020.